Results 41 to 50 of about 1,896 (179)

Prevalence of asymptomatic parasitaemia among household members of children under seasonal malaria chemoprevention coverage and comparison of the performance of standard rapid diagnostic tests versus ultrasensitive RDT for the detection of asymptomatic parasitaemia in Nanoro, Burkina Faso. [PDF]

Parasitol Res
Kambou SAE, Millogo KS, Sondo P, Kabore B, Kouevi AFC, Bouda I, Rouamba T, Derra K, Tahita MC, Ilboudo H, Rouamba E, Tougri G, Otienoburu SD, Dhorda M, Bamba S, Guerin PJ, Tinto H.   +16 more
europepmc   +2 more sources

Spontaneous adverse drug reaction reporting during the seasonal malaria chemoprevention campaign in 2022

Bulletin of the National Research Centre, 2023
Background Seasonal administration of antimalaria drug, sulphadoxine/pyrimethamine plus amodiaquine to children 3–59 months is a malaria preventive intervention used for the reduction of childhood malaria morbidity and mortality in area with highly ...
Kunle Rotimi, Babatunde Fagbemi, Taiwo Ibinaiye, Jimmy Aiden, Victor Gabriel, Chrysantus Dabes, Tapshak Kyeshir, Daniel Oguche, Omolola Obayemi, Aminu Biambo, Andrew Okwulu, Adaeze Aidenagbon   +11 more
doaj   +1 more source

Malaria chemoprevention and drug resistance: a review of the literature and policy implications

Malaria Journal, 2022
Chemoprevention strategies reduce malaria disease and death, but the efficacy of anti-malarial drugs used for chemoprevention is perennially threatened by drug resistance.
Christopher V. Plowe
doaj   +1 more source

Shifts in the clinical epidemiology of severe malaria after scaling up control strategies in Mali

Frontiers in Neurology, 2022
A decrease in malaria incidence following implementation of control strategies such as use of artemisinin-based combination therapies, insecticide-impregnated nets, intermittent preventive treatment during pregnancy and seasonal malaria chemoprevention ...
Drissa Coulibaly, Abdoulaye K. Kone, Bourama Kane, Bouréima Guindo, Bourama Tangara, Mody Sissoko, Fayçal Maiga, Karim Traore, Aichatou Diawara, Amidou Traore, Ali Thera, Mahamadou S. Sissoko, Ogobara K. Doumbo, Mark A. Travassos, Mahamadou A. Thera   +14 more
doaj   +1 more source

Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trial. [PDF]

BMJ Open
Moreno M, Barry A, Gmeiner M, Yaro JB, Sermé SS, Byrne I, Ramjith J, Ouedraogo A, Soulama I, Grignard L, Soremekun S, Koele S, Ter Heine R, Ouedraogo AZ, Sawadogo J, Sanogo E, Ouedraogo IN, Hien D, Sirima SB, Bradley J, Bousema T, Drakeley C, Tiono AB.   +22 more
europepmc   +3 more sources

Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention [PDF]

New England Journal of Medicine, 2019
Mass administration of azithromycin for trachoma control led to a sustained reduction in all-cause mortality among Ethiopian children. Whether the addition of azithromycin to the monthly sulfadoxine-pyrimethamine plus amodiaquine used for seasonal malaria chemoprevention could reduce mortality and morbidity among African children was unclear.We ...
Ismaila Thera, Brian Greenwood, Samba Coumare, Jean-Bosco Ouédraogo, Irene Kuepfer, Amadou Tapily, Halidou Tinto, Ogobara K. Doumbo, Amadou Barry, Frederic Nikiema, S. Yerbanga, Abdourhamane Traore, Issaka Zongo, Alassane Dicko, Issaka Sagara, Daniel Chandramohan, Matthew Cairns, Modibo Diarra, Paul Milligan   +18 more
openaire   +3 more sources

Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine-pyrimethamine five years (2016-2020) after the implementation of seasonal malaria chemoprevention in Cameroon. [PDF]

Wellcome Open Res
Tchuenkam PVK, Ngum LN, Ali IM, Chedjou JPK, Nji AM, Netongo PM, Ngwafor R, Niba PTN, Tah CF, Nana WD, Ekoyol G, Bigoga JD, Ashu DF, Tume CB, Mbacham WF.   +14 more
europepmc   +2 more sources

Seasonal Malaria Chemoprevention Coverage in Guinea in 2019 [PDF]

, 2020
SMC involves the administration of a treatment course of sulfadoxine-pyrimethamine plus amodiaquine once a month to children aged 3 59 months during the high risk period each year to prevent malaria. SMC over 4 months of the year was introduced in Guinea in 2015 in 6 prefectures, scaling up to 13 prefectures by 2018.
Loua, Kovana Marcel, Milligan, Paul
openaire   +2 more sources

Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria [PDF]

BMJ Global Health, 2022
BackgroundIn 2012, the WHO issued a policy recommendation for the use of seasonal malaria chemoprevention (SMC) to children 3–59 months in areas of highly seasonal malaria transmission. Clinical trials have found SMC to prevent around 75% of clinical malaria.
Monica Anna de Cola, Benoît Sawadogo, Sol Richardson, Taiwo Ibinaiye, Adama Traoré, Cheick Saïd Compaoré, Chibuzo Oguoma, Olusola Oresanya, Gauthier Tougri, Christian Rassi, Arantxa Roca-Feltrer, Patrick Walker, Lucy C Okell   +12 more
openaire   +5 more sources

Combining malaria vaccination with chemoprevention: a promising new approach to malaria control

Malaria Journal, 2021
Malaria control has stalled in a number of African countries and novel approaches to malaria control are needed for these areas. The encouraging results of a recent trial conducted in young children in Burkina Faso and Mali in which a combination of the ...
Brian Greenwood, Matthew Cairns, Mike Chaponda, R. Matthew Chico, Alassane Dicko, Jean-Bosco Ouedraogo, Kamija S. Phiri, Feiko O. ter Kuile, Daniel Chandramohan   +8 more
doaj   +1 more source